These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 23529597

  • 1. [Non-alcoholic fatty liver disease in obese children and adolescents].
    Denzer C.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):517-27. PubMed ID: 23529597
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K, Resuli B, Petrela E, Malaj V, Jaze H.
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [Abstract] [Full Text] [Related]

  • 4. [Cardiovascular risk factors in childhood. An anamnestic guideline].
    Dalla Pozza R.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):487-91. PubMed ID: 23529592
    [Abstract] [Full Text] [Related]

  • 5. [Carbohydrate metabolism disorders among obese children and adolescents. Diabetes mellitus type 2].
    Sergeyev E, Wagner I, Neef M, Adler M, Körner A, Kiess W.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):511-6. PubMed ID: 23529596
    [Abstract] [Full Text] [Related]

  • 6. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 7. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
    Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
    [Abstract] [Full Text] [Related]

  • 8. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM, El-Raziky MS, Fouad HM, Anwar GM, El-Mougy FM, El-Koofy NM, El-Hennawy AM.
    Diabetes Metab Syndr; 2015 Jul; 9(2):114-9. PubMed ID: 25470627
    [Abstract] [Full Text] [Related]

  • 9. [Childhood and adolescent obesity--consequences for the locomotor system and treatment options. Musculoskeletal complications of overweight children and adolescents].
    Schönau E.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):528-31. PubMed ID: 23529598
    [Abstract] [Full Text] [Related]

  • 10. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D, Schattenberg JM.
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [Abstract] [Full Text] [Related]

  • 11. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.
    Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE.
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):413-27. PubMed ID: 17033514
    [Abstract] [Full Text] [Related]

  • 12. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.
    Schwimmer JB.
    Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977
    [Abstract] [Full Text] [Related]

  • 13. [Pediatric non-alcoholic fatty liver disease: recent advances and challenges].
    Poggiogalle E, Olivero G, Anania C, Ferraro F, Pacifico L.
    Minerva Pediatr; 2010 Dec; 62(6):569-84. PubMed ID: 21042270
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic approaches for obesity and comorbidities in young immigrants].
    Wiegand S, Babitsch B.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):543-50. PubMed ID: 23529601
    [Abstract] [Full Text] [Related]

  • 15. Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents?
    Rodríguez G, Gallego S, Breidenassel C, Moreno LA, Gottrand F.
    Nutr Hosp; 2010 Apr; 25(5):712-7. PubMed ID: 21336425
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiology of non-alcoholic steatohepatitis and basis for treatment.
    Pinzani M.
    Dig Dis; 2011 Apr; 29(2):243-8. PubMed ID: 21734391
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pediatric non-alcoholic fatty liver disease: an increasing public health issue.
    Berardis S, Sokal E.
    Eur J Pediatr; 2014 Feb; 173(2):131-9. PubMed ID: 24068459
    [Abstract] [Full Text] [Related]

  • 19. [Non-alcoholic fatty liver].
    Tagle Arrospide M.
    Rev Gastroenterol Peru; 2003 Feb; 23(1):49-57. PubMed ID: 12768215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.